Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.1900
-0.0090 (-4.52%)
Nov 17, 2025, 4:00 PM EST
Renalytix Market Cap
Renalytix has a market cap or net worth of $41.74 million as of November 17, 2025. Its market cap has increased by 112.04% in one year.
Market Cap
41.74M
Enterprise Value
46.16M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 41.74M, a decrease of -50.59%. That is a compound annual growth rate of -9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 39.40M | -11.62% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | 479.42M | 67.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 724.59M |
| Glass House Brands | 512.09M |
| American Oncology Network | 369.77M |
| Northwest Biotherapeutics | 368.68M |
| CytoDyn | 333.83M |
| Silence Therapeutics | 322.61M |
| Nika Pharmaceuticals | 311.89M |